Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Stockholders' Equity
QFR327385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
687,635.00
Year-over-Year Change
6.82%
Date Range
10/1/2000 - 4/1/2025
Summary
This trend tracks the stockholders' equity for U.S. pharmaceutical and medicine corporations on a quarterly basis. It provides critical insight into the financial health and investment potential of a key sector in the American economy.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
Stockholders' equity represents the net value of a corporation, calculated as total assets minus total liabilities. For pharmaceutical companies, this metric reflects their accumulated financial strength, research investment capacity, and overall market valuation.
Methodology
Data is collected through mandatory financial reporting by publicly traded pharmaceutical corporations, compiled and standardized by the U.S. Federal Reserve.
Historical Context
Economists and investors use this trend to assess sector-wide financial performance, investment trends, and potential regulatory or market impacts on pharmaceutical companies.
Key Facts
- Represents quarterly financial snapshot of U.S. pharmaceutical corporations
- Indicates cumulative net worth of pharmaceutical companies
- Useful for assessing sector-wide financial stability and growth potential
FAQs
Q: What does stockholders' equity indicate?
A: Stockholders' equity represents the total net value of a company, showing what shareholders would theoretically receive if all assets were liquidated and debts paid.
Q: Why is this trend important for investors?
A: It provides a key metric for evaluating a company's financial health, potential for growth, and overall market performance in the pharmaceutical sector.
Q: How often is this data updated?
A: The data is updated quarterly, providing a consistent and current view of the pharmaceutical industry's financial landscape.
Q: Can this trend predict industry performance?
A: While not a definitive predictor, consistent growth in stockholders' equity can signal strong financial management and potential future success.
Q: What are the limitations of this metric?
A: Stockholders' equity is a snapshot in time and should be analyzed alongside other financial indicators for comprehensive insights.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Nonmetallic Mineral Products: Capital Stock and Other Capital (Less Treasury Stock)
QFRD326327USNO
Quarterly Financial Report: U.S. Corporations: Chemicals: Retained Earnings at Beginning of Quarter
QFRD119CHEUSNO
Quarterly Financial Report: U.S. Corporations: Apparel and Leather Products: Net Working Capital
QFRNWCANLUSNO
Quarterly Financial Report: U.S. Corporations: All Nondurable Manufacturing: Income (Loss) from Operations
QFR104NDUUSNO
Quarterly Financial Report: U.S. Corporations: All Other Chemicals: Net Property, Plant, and Equipment
QFR219325USNO
Quarterly Financial Report: U.S. Corporations: Foundries: Retained Earnings at End of Quarter
QFRD123331USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Stockholders' Equity [QFR327385USNO], retrieved from FRED.
Last Checked: 8/1/2025